RxDoctor Payments DataLook up a doctor →

Kamran Tasharofi, MD

Internal Medicine · Garwood, NJNPI 1174595466

Payments from drug & device makers

$431,582in general payments, 2019–2025

Across 796 payments — averaging $542.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$384K
  • AbbVie$32K
  • Novartis$3K
  • Lilly USA, LLC$1K
  • Genentech USA, Inc.$1K
  • AstraZeneca$1K
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
SPR Therapeutics, Inc12$383,629
AbbVie(2 entities)104$31,735
Novartis21$2,982
Lilly USA, LLC88$1,423
Genentech USA, Inc.13$1,409
AstraZeneca70$1,171
Senseonics, Incorporated20$1,150
GSK50$905
Pfizer67$777
Abbott22$587
Boehringer Ingelheim28$585
Novo Nordisk73$444
Amarin Pharma, Inc.23$409
Merz North America, Inc.5$400
Ardelyx, Inc.6$317
Sanofi-aventis U.S. LLC19$285
Dexcom, Inc.14$264
Exact Sciences9$226
Merck15$213
Axsome Therapeutics, Inc.5$195
Amgen(2 entities)12$169
Johnson & Johnson(3 entities)11$153
Takeda Pharmaceuticals U.S.A., Inc.10$152
Medtronic1$141
Otsuka America Pharmaceutical, Inc.8$140
Inari Medical, Inc.1$133
Daiichi Sankyo Inc.9$132
Corcept Therapeutics7$127
Janssen Scientific Affairs, LLC1$125
Bayer6$119
Scilex Pharmaceuticals Inc.7$106
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$102
Bioventus LLC4$92
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$90
Astellas Pharma US Inc4$77
Arbor Pharmaceuticals, Inc.4$59
Mannkind Corporation3$48
Atricure, Inc.1$40
Xeris Pharmaceuticals, Inc.2$32
Ironwood Pharmaceuticals, Inc2$32
Eisai Inc.2$29
Radius Health, Inc.2$28
Mylan Specialty L.p.2$27
Biogen2$27
Sunovion Pharmaceuticals Inc.1$27
Cequr Corporation1$24
Teva Pharmaceuticals USA, Inc.2$23
Ferring Pharmaceuticals Inc.1$21
Neurocrine Biosciences, Inc.1$20
Phathom Pharmaceuticals, Inc.1$18
Nevro Corp.1$17
Lundbeck LLC1$17
Bigfoot Biomedical Inc1$17
Bausch Health US, LLC1$15
Regeneron Healthcare Solutions, Inc.1$15
Biohaven Pharmaceuticals, Inc.1$15
Echosens North America, Inc.1$15
Optinose US, Inc.1$15
Vanda Pharmaceuticals Inc.1$14
Althera Pharmaceuticals LLC1$13

How this compares

$431,582 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024
$1,182,387
Medicare patients
1,338
Services billed
22,399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Garwood

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →